Randox has introduced three levels of maternal-screening control serum for use in monitoring the accuracy and reproducibility of analytes, covering both first- and second-trimester screening tests.
Randox has introduced three levels of maternal-screening control serum for use in monitoring the accuracy and reproducibility of analytes, covering both first- and second-trimester screening tests.
Analytes include AFP, Free-b-hCG, Inhibin A, PAPP-A, Total hCG and unconjugated oestriol.
These new controls are 100 per cent human in origin and contain accurately assigned target values and ranges for the most common immunoassay analysers.
Analyte levels are set in accordance with those typically found during pregnancy.
Unconjugated oestriol levels are more appropriate than those offered by other suppliers.
All Randox quality controls are third party: they are not designed or optimised for use with a specific manufacturer's instrument, calibrator or reagent.
In addition to the extensive range of quality-control materials, Randox provides an internet-driven peer-group reporting system, and RIQAS, an external quality-assurance scheme providing customers with a choice of 15 EQA programmes, including maternal screening.
